cms_DE: 63

In collaboration with The Seattle Times, Big Local News is providing full-text nursing home deficiencies from Centers for Medicare & Medicaid Services (CMS). These files contain the full narrative details of each nursing home deficiency cited regulators. The files include deficiencies from Standard Surveys (routine inspections) and from Complaint Surveys. Complete data begins January 2011 (although some earlier inspections do show up). Individual states are provides as CSV files. A very large (4.5GB) national file is also provided as a zipped archive. New data will be updated on a monthly basis. For additional documentation, please see the README.

Data source: Big Local News · About: big-local-datasette

This data as json, copyable

rowid facility_name facility_id address city state zip inspection_date deficiency_tag scope_severity complaint standard eventid inspection_text filedate
63 WILLOWBROOKE COURT AT COUNTRY HOUSE 85003 4830 KENNETT PIKE WILMINGTON DE 19807 2018-07-18 756 D 0 1 9EWR11 **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and interview, it was determined that the facility failed to act on irregularities identified during a medication regimen review (MRR) by the pharmacist for one (R29) out of 23 residents sampled. Findings include: Cross refer F758 Review of R29's clinical record revealed: On 5/14/18, a physician's orders [REDACTED]. MRR's were completed by the consultant pharmacist for R29 for (MONTH) (YEAR), (MONTH) (YEAR), and (MONTH) (YEAR) with identified irregularities on 5/16/18 and 7/10/18. On 5/16/18, the pharmacist recommendation stated that R29 received an antipsychotic ([MEDICATION NAME]), but did not have a supporting indication for use documented. If current therapy was to continue, R29's chart needed to be updated to include: the specific diagnosis/indication that required treatment, and a list of the symptoms or target behaviors. On 6/1/18, E7 (medical director) responded to the pharmacist recommendation and changed the [DIAGNOSES REDACTED]. E7 signed this recommendation on 6/1/18. On 6/8/18 a new order was entered for R29 to receive [MEDICATION NAME] 5 mg 1 tablet at bedtime for depression. On 7/10/18, the pharmacist recommendation stated that R29 received [MEDICATION NAME] for depression without a concomitant anti-depressant. The pharmacist recommended that R29 should have been evaluated for the continued use of [MEDICATION NAME] for depression and if anti-psychotic therapy was to continue, detailed documentation of the specific [DIAGNOSES REDACTED]. E7 responded to the pharmacist recommendation stating to change R29's [MEDICATION NAME] [DIAGNOSES REDACTED]. On 7/13/18, a new order was entered for R29 to receive [MEDICATION NAME] 5 mg 1 tablet at bedtime for [MEDICAL CONDITION]/hallucinations. The facility failed to act on an irregularity identified by the pharmacist during the MRR on 6/1/18 to change R29's [MEDICATION NAME] diagnosis. R29's [MEDICATION NAME] [DIAGNOSES REDACTED]. Findings were reviewed with E2 (DON) and E3 (ADON) on 7/18/18 at approximately 2:00 PM. 2020-09-01